Anika Therapeutics
ANIK
ANIK
166 hedge funds and large institutions have $726M invested in Anika Therapeutics in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 159 → 166 (+7)
0.5% more ownership
Funds ownership: 84.42% → 84.91% (+0.5%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
166
Holding in Top 10
2
Calls
$2.67M
Puts
$1.7M
Top Buyers
| 1 | +$13.5M | |
| 2 | +$7.42M | |
| 3 | +$6.16M | |
| 4 |
Bank of New York Mellon
New York
|
+$2.96M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.44M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$8.46M | |
| 3 | -$5.79M | |
| 4 |
Two Sigma Investments
New York
|
-$3.3M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$2.25M |